Investing.com - Liminal BioSciences Inc reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Liminal BioSciences Inc announced earnings per share of C$-0.150 on revenue of C$3K. Analysts polled by Investing.com EPS of C$-0.140 on revenue of C$1.09M.
Liminal BioSciences Inc 's are up 86.39% and is trading at C$0.495 , still down 70.50% from its 52 week high of C$1.68 set on Wednesday, November 10, 2021.
Liminal BioSciences Inc follows other major Healthcare sector earnings this month
Liminal BioSciences Inc's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of C$5.79 on revenue of C$80.89B, EPS of C$5.43 on revenue of C$80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of C$2.55 on revenue of C$23.79B, for EPS of C$2.52 on revenue of C$23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar